News tagged with cyclosporine
Ciclosporin
Ciclosporin (INN/BAN) (pronounced /ˌsaɪkləˈspɔrɪn/), cyclosporine (USAN), cyclosporin (former BAN), or cyclosporin A is an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the immune system, and therefore the risk of organ rejection. Initially isolated from the fungus Tolypocladium inflatum isolated from a soil sample obtained by Sandoz scientists at Hardangervidda, Norway in 1969, ciclosporin is a cyclic nonribosomal peptide of 11 amino acids and contains a single D-amino acid, which are rarely encountered in nature.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Doctors' perceptions of psoriasis therapies vary
(HealthDay)—Doctors who treat patients with psoriasis show wide variation in their beliefs about the safety and effectiveness of psoriasis treatments, according to a study published in the February issue ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
A step forward in the treatment of chronic urticaria
An international study involving dermatologists from the Hospital del Mar and Spanish subjects has concluded that a drug normally used to treat severe bronchial asthma caused by allergies (Omalizumab) rapidly eliminates the ...
Diseases, Conditions, Syndromes
Mar 20, 2013 |
5 / 5 (1) |
0
Choice of psoriasis treatment affects CVD event rates
(HealthDay)—Compared with other anti-psoriatic therapies, systemic anti-inflammatory treatment of patients with severe psoriasis with biologic agents or methotrexate is associated with a lower combined ...
Immunology
Sep 27, 2012 |
not rated yet |
0
Circulating blood factor linked with a leading cause of kidney failure
Patients with a disease that is a leading cause of kidney failure tend to have high levels of a particular factor circulating in their blood, according to a study appearing in an upcoming issue of the Journal of the American ...
Diseases, Conditions, Syndromes
Nov 08, 2012 |
not rated yet |
0
Belatacept after a kidney transplant: Minor added benefit for certain patients
Belatacept (trade name Nulojix) has been approved since June 2011 to prevent a rejection reaction of the body to the donor organ (transplant) in adults who have received a kidney transplant. The Institute for Quality and ...
Medications
Nov 09, 2012 |
not rated yet |
0
Best post-transplant drug regimen identified for patients with new kidneys
For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive ...
Other
Jul 29, 2011 |
not rated yet |
0
